PharmacogenomicsVol. 13, No. 6 EditorialNext-generation sequencing in breast cancer: translational science and clinical integrationMilan RadovichMilan RadovichDepartment of Surgery, Section of General Surgery, Indiana University School of Medicine, Indianapolis, IN, USA. Search for more papers by this authorEmail the corresponding author at mradovic@iupui.eduPublished Online:19 Apr 2012https://doi.org/10.2217/pgs.12.18AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInReddit View articleKeywords: breast cancerclinicalgenomic oncologygenomicsnext-generation sequencingtranscriptomicstranslationalReferences1 Lander ES, Linton LM, Birren B et al. Initial sequencing and analysis of the human genome. Nature409(6822),860–921 (2001).Crossref, Medline, CAS, Google Scholar2 Venter JC, Adams MD, Myers EW et al. The sequence of the human genome. Science291(5507),1304–1351 (2001).Crossref, Medline, CAS, Google Scholar3 Mardis ER. A decade’s perspective on DNA sequencing technology. Nature470(7333),198–203 (2011).Crossref, Medline, CAS, Google Scholar4 Meyerson M, Gabriel S, Getz G. Advances in understanding cancer genomes through second-generation sequencing. Nat. Rev. Genet.11(10),685–696 (2010).Crossref, Medline, CAS, Google Scholar5 Ley TJ, Mardis ER, Ding L et al. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature456(7218),66–72 (2008).Crossref, Medline, CAS, Google Scholar6 Hudson TJ, Anderson W, Artez A et al. International network of cancer genome projects. Nature464(7291),993–998 (2010).Crossref, Medline, CAS, Google Scholar7 Stephens PJ, McBride DJ, Lin ML et al. Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature462(7276),1005–1010 (2009).Crossref, Medline, CAS, Google Scholar8 Turner N, Tutt A, Ashworth A. Hallmarks of ‘BRCAness’ in sporadic cancers. Nat. Rev. Cancer4(10),814–819 (2004).Crossref, Medline, CAS, Google Scholar9 Farmer H, McCabe N, Lord CJ et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature434(7035),917–921 (2005).Crossref, Medline, CAS, Google Scholar10 Robinson DR, Kalyana-Sundaram S, Wu YM et al. Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer. Nat. Med.17(12),1646–1651 (2011).Crossref, Medline, CAS, Google Scholar11 Shah SP, Morin RD, Khattra J et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature461(7265),809–813 (2009).Crossref, Medline, CAS, Google Scholar12 Ding L, Ellis MJ, Li S et al. Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature464(7291),999–1005 (2010).Crossref, Medline, CAS, Google Scholar13 Navin N, Kendall J, Troge J et al. Tumour evolution inferred by single-cell sequencing. Nature472(7341),90–94 (2011).Crossref, Medline, CAS, Google Scholar14 Futreal PA. Leveraging next generation sequencing in the study of breast cancer somatic genetics. Presented at: San Antonio Breast Cancer Symposium. San Antonio, TX, USA, 8–12 December 2010.Google Scholar15 Ellis MJ, Ding L, Shen D et al. Analysis of luminal-type breast cancer by massively parallel sequencing. Presented at: American Association for Cancer Research Annual Meeting. Orlando, FL, USA, 2–6 April 2011 (Abstract 87).Google Scholar16 Gustin JP, Cosgrove DP, Park BH. The PIK3CA gene as a mutated target for cancer therapy. Curr. Cancer Drug Targets8(8),733–740 (2008).Crossref, Medline, CAS, Google Scholar17 O’Shaughnessy J, Craig DW, Kiefer J et al. Next generation sequencing reveals co-activating events in the MAPK and PI3K/AKT pathways in metastatic triple negative breast cancers. Presented at: San Antonio Breast Cancer Symposium. San Antonio, TX, USA, 6–10 December 2011.Google Scholar18 Roychowdhury S, Iyer MK, Robinson DR et al. Personalized oncology through integrative high-throughput sequencing: a pilot study. Sci. Transl. Med.3(111),111ra121 (2011).Crossref, Medline, Google Scholar101 clinicaltrials.gov. www.clinicaltrials.govGoogle ScholarFiguresReferencesRelatedDetailsCited BySpecimens for Molecular Testing in Breast Cancer13 August 2015Breast TumorsBiomarker Testing for Breast, Lung, and Gastroesophageal Cancers at NCI Designated Cancer Centers12 September 2014 | JNCI: Journal of the National Cancer Institute, Vol. 106, No. 10Theranostic and Molecular Classification of Breast CancerArchives of Pathology & Laboratory Medicine, Vol. 138, No. 1Molecular and Cellular Heterogeneity in Breast CancerThe American Journal of Pathology, Vol. 183, No. 4Breast Cancer Heterogeneity in Primary and Metastatic Disease9 November 2012Breast cancer pharmacogenomics: where we are goingWilliam G Newman & Dave Flockhart19 April 2012 | Pharmacogenomics, Vol. 13, No. 6 Vol. 13, No. 6 Follow us on social media for the latest updates Metrics Downloaded 692 times History Published online 19 April 2012 Published in print April 2012 Information© Future Medicine LtdKeywordsbreast cancerclinicalgenomic oncologygenomicsnext-generation sequencingtranscriptomicstranslationalFinancial & competing interests disclosureThe author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.No writing assistance was utilized in the production of this manuscript.PDF download